LPL and type 2 diabetes mellitus: This study was specifically designed to test the hypothesis that the inclusion of NDGA, the functional role of which is to be an LPL inhibitor, exacerbates metabolic complications and alters HDL subclasses in the type-2 diabetes mice model, db/db mice.